Literature DB >> 11119580

Alteration of zinc-binding residues of simian immunodeficiency virus p8(NC) results in subtle differences in gag processing and virion maturation associated with degradative loss of mutant NC.

J L Yovandich1, E N Chertova, B P Kane, T D Gagliardi, J W Bess, R C Sowder, L E Henderson, R J Gorelick.   

Abstract

In all retroviruses analyzed to date (except for the spumaretroviruses), the Zn(2+)-coordinating residues of nucleocapsid (NC) perform or assist in crucial reactions necessary to complete the retrovirus life cycle. Six replication-defective mutations have been engineered in the two NC Zn(2+) fingers (ZFs) of simian immunodeficiency virus [SIV(Mne)] that change or delete specific Zn(2+)-interacting Cys residues and were studied by using electron microscopy, reversed-phase high-performance liquid chromatography, immunoblotting, and RNA quantification. We focused on phenotypes of produced particles, specifically morphology, Gag polyprotein processing, and genomic RNA packaging. Phenotypes were similar among viruses containing a point or deletion mutation involving the same ZF. Mutations in the proximal ZF (ZF1) resulted in near-normal Gag processing and full-length genomic RNA incorporation and were most similar to wild-type (WT) virions with electron-dense, conical cores. Mutation of the distal ZF, as well as point mutations in both ZFs, resulted in more unprocessed Gag proteins than a deletion or point mutation in ZF1, with an approximate 30% reduction in levels of full-length genomic RNA in virions. These mutant virions contained condensed cores; however, the cores typically appeared less electron dense and more rod shaped than WT virions. Surprisingly, deletion of both ZFs, including the basic linker region between the ZFs, resulted in the most efficient Gag processing. However, genomic RNA packaging was approximately 10% of WT levels, and those particles produced were highly abnormal with respect to size and core morphology. Surprisingly, all NC mutations analyzed demonstrated a significant loss of processed NC in virus particles, suggesting that Zn(2+)-coordinated NC is protected from excessive proteolytic cleavage. Together, these results indicate that Zn(2+) coordination is important for correct Gag precursor processing and NC protein stability. Additionally, SIV particle morphology appears to be the result of proper and complete Gag processing and relies less on full-length genomic RNA incorporation, as dictated by the Zn(2+) coordination in the ZFs of the NC protein.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11119580      PMCID: PMC113904          DOI: 10.1128/JVI.75.1.115-124.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA.

Authors:  R J Gorelick; S M Nigida; J W Bess; L O Arthur; L E Henderson; A Rein
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

2.  Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease.

Authors:  S Erickson-Viitanen; J Manfredi; P Viitanen; D E Tribe; R Tritch; C A Hutchison; D D Loeb; R Swanstrom
Journal:  AIDS Res Hum Retroviruses       Date:  1989-12       Impact factor: 2.205

3.  Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis.

Authors:  F Mammano; A Ohagen; S Höglund; H G Göttlinger
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

4.  In situ processing of a retroviral nucleocapsid protein by the viral proteinase.

Authors:  M M Roberts; T D Copeland; S Oroszlan
Journal:  Protein Eng       Date:  1991-08

5.  Evidence that a central domain of nucleocapsid protein is required for RNA packaging in murine leukemia virus.

Authors:  A Rein; D P Harvin; J Mirro; S M Ernst; R J Gorelick
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

6.  Effect of rearrangements and duplications of the Cys-His motifs of Rous sarcoma virus nucleocapsid protein.

Authors:  N E Bowles; P Damay; P F Spahr
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

7.  Studies on the substrate specificity of the proteinase of equine infectious anemia virus using oligopeptide substrates.

Authors:  J Tözsér; D Friedman; I T Weber; I Bláha; S Oroszlan
Journal:  Biochemistry       Date:  1993-04-06       Impact factor: 3.162

8.  Tightly bound zinc in human immunodeficiency virus type 1, human T-cell leukemia virus type I, and other retroviruses.

Authors:  J W Bess; P J Powell; H J Issaq; L J Schumack; M K Grimes; L E Henderson; L O Arthur
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

9.  The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent.

Authors:  R J Gorelick; D J Chabot; A Rein; L E Henderson; L O Arthur
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

10.  Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues.

Authors:  J Dannull; A Surovoy; G Jung; K Moelling
Journal:  EMBO J       Date:  1994-04-01       Impact factor: 11.598

View more
  14 in total

1.  Subtle alterations of the native zinc finger structures have dramatic effects on the nucleic acid chaperone activity of human immunodeficiency virus type 1 nucleocapsid protein.

Authors:  Jianhui Guo; Tiyun Wu; Bradley F Kane; Donald G Johnson; Louis E Henderson; Robert J Gorelick; Judith G Levin
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  Functional replacement of nucleocapsid flanking regions by heterologous counterparts with divergent primary sequences: effects of chimeric nucleocapsid on the retroviral replication cycle.

Authors:  William Fu; Wei-Shau Hu
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Protection of Macaca nemestrina from disease following pathogenic simian immunodeficiency virus (SIV) challenge: utilization of SIV nucleocapsid mutant DNA vaccines with and without an SIV protein boost.

Authors:  R J Gorelick; R E Benveniste; J D Lifson; J L Yovandich; W R Morton; L Kuller; B M Flynn; B A Fisher; J L Rossio; M Piatak; J W Bess; L E Henderson; L O Arthur
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 4.  Properties and functions of the nucleocapsid protein in virus assembly.

Authors:  Delphine Muriaux; Jean-Luc Darlix
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

5.  Role of murine leukemia virus nucleocapsid protein in virus assembly.

Authors:  Delphine Muriaux; Sylvain Costes; Kunio Nagashima; Jane Mirro; Ed Cho; Stephen Lockett; Alan Rein
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

6.  Molecular mechanisms of simian immunodeficiency virus SIV(agm) RNA encapsidation.

Authors:  William Fu; V V S P Prasad; Jianbo Chen; Olga Nikolaitchik; Wei-Shau Hu
Journal:  Virology       Date:  2007-02-26       Impact factor: 3.616

7.  Structure of the zinc finger domain encompassing residues 13-51 of the nucleocapsid protein from simian immunodeficiency virus.

Authors:  Nelly Morellet; Hervé Meudal; Serge Bouaziz; Bernard Pierre Roques
Journal:  Biochem J       Date:  2006-02-01       Impact factor: 3.857

8.  Small-molecule inactivation of HIV-1 NCp7 by repetitive intracellular acyl transfer.

Authors:  Lisa M Miller Jenkins; David E Ott; Ryo Hayashi; Lori V Coren; Deyun Wang; Qun Xu; Marco L Schito; John K Inman; Daniel H Appella; Ettore Appella
Journal:  Nat Chem Biol       Date:  2010-10-17       Impact factor: 15.040

9.  Functional complementation of nucleocapsid and late domain PTAP mutants of human immunodeficiency virus type 1 during replication.

Authors:  Olga A Nikolaitchik; Robert J Gorelick; Maria G Leavitt; Vinay K Pathak; Wei-Shau Hu
Journal:  Virology       Date:  2008-03-19       Impact factor: 3.616

10.  Pan-retroviral Nucleocapsid-Mediated Phase Separation Regulates Genomic RNA Positioning and Trafficking.

Authors:  Anne Monette; Meijuan Niu; Lois Chen; Shringar Rao; Robert James Gorelick; Andrew John Mouland
Journal:  Cell Rep       Date:  2020-04-21       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.